(19)
(11) EP 4 798 617 A1

(12)

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24805298.7

(22) Date of filing: 24.10.2024
(51) International Patent Classification (IPC): 
C07K 16/00(2006.01)
G01N 30/86(2006.01)
G01N 30/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/00; C07K 2317/31; C07K 2317/52; C07K 2317/56; C07K 2317/622; G01N 30/8693; C40B 30/10; G01N 2500/04; G01N 2030/8831; G01N 30/96
(86) International application number:
PCT/US2024/052797
(87) International publication number:
WO 2025/090753 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 26.10.2023 US 202363545879 P

(71) Applicant: Amgen Inc.
Thousand Oaks, CA 91320-1799 (US)

(72) Inventors:
  • PARTIN, Alexander
    Thousand Oaks, California 91320-1799 (US)
  • MIRTS, Evan Neal
    Thousand Oaks, California 91320-1799 (US)
  • GONG, Danyang
    Thousand Oaks, California 91320-1799 (US)
  • RILEY, Timothy Patrick
    Thousand Oaks, California 91320-1799 (US)
  • GARCES, Fernando
    Thousand Oaks, California 91320-1799 (US)

(74) Representative: Lau, Sarah Jane 
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) LEVERAGING NATIVE ANTIBODY PROPERTIES TO GUIDE BISPECIFIC SELECTION